Coma with diffuse white matter hemorrhages in juvenile diabetic ketoacidosis

Pediatrics

Volumn 120, Issue 6, 2007, Pages

  Mahmud, Farid H ^a   Ramsay, David A ^a   Levin, Simon D ^a   Singh, Ram N ^a   Kotylak, Trevor ^a   Fraser, Douglas D ^a  

^a CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

Diabetes; DKA; Hemorrhage; White matter changes

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GLUCOSE; INSULIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ANAMNESIS; ARTICLE; ASYSTOLE; AUTOPSY; BRAIN EDEMA; BRAIN HEMORRHAGE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; COGNITIVE DEFECT; COMA; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC KETOACIDOSIS; DIALYSIS; FAMILY HISTORY; FEMALE; FLU LIKE SYNDROME; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERKALEMIA; JUVENILE DIABETES MELLITUS; LETHARGY; LUNG EDEMA; NECROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PEDIATRICS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; VOMITING; WHITE MATTER;

ADOLESCENT; CHILD; COMA; DIABETIC KETOACIDOSIS; FATAL OUTCOME; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES;

EID: 36849067413     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0366     Document Type: Article

References (48)

1. Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146:688-692
2. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85:16-22
3. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344:264-269
4. Dillon ES, Riggs HE, Wallace Dyer W. Cerebral lesions in uncomplicated fatal diabetic acidosis. Am J Med Sci. 1936;192:360-365
5. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 1990;13:22-33
6. Roe TF, Crawford TO, Huff KR, et al. Brain infarction in children with diabetic ketoacidosis. J Diabetes Complications. 1996;10:100-108
7. Muir AB, Quisling RG, Yang MC, et al. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004;27:1541-1546
8. Rosenbloom AL. Hyperglycemic comas in children: new insights into pathophysiology and management. Rev Endocr Metab Disord. 2005;6:297-306
9. Rogers B, Sills I, Cohen M, et al. Diabetic ketoacidosis: neurologic collapse during treatment followed by severe developmental morbidity. Clin Pediatr (Phila). 1990;29:451-456
10. Atkin SL, Coady AM, Horton D, Sutaria N, Sellars L, Walton C. Multiple cerebral haematomata and peripheral nerve palsies associated with a case of juvenile diabetic ketoacidosis. Diabet Med. 1995;12:267-270
11. Ho J, Mah JK, Hill MD, Pacaud D. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes. 2006;7:116-121
12. Atluru VL. Spontaneous intracerebral hematomas in juvenile diabetic ketoacidosis. Pediatr Neurol. 1986;2:167-169
13. Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes. 2001;2:109-114
14. Keane S, Gallagher A, Ackroyd S, McShane MA, Edge JA. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child. 2002;86:204-205
15. Ishida K, Shimizu H, Hida H, Urakawa S, Ida K, Nishino H. Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive. Neuroscience. 2004;125:633-644
16. Lévy-Marchal C, Patterson CC, Green A, et al. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Diabetes. Diabetologia. 2001;44(suppl 3):B75-B80
17. Lindblad B, Blom L, Hanas R, et al. Metabolic acidosis at the onset of diabetes is frequent at all pediatric ages. J Pediatr Endocrinol Metab. 2002;15:1081
18. Mel JM, Werther GA. Incidence and outcome of diabetic cerebral oedema in childhood: are there predictors? J Paediatr Child Health. 1995;31:17-20
19. Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:1150-1159
20. Carmassi F, Morale M, Pucetti R, et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res. 1992;67:643-654.
21. Dalton RR, Hoffman WH, Passmore GG, Martin SL. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci. 2003;33:435-442
22. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079-2086
23. Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003;108:175-181
24. Stentz FB, Kitabchi AE. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun. 2005;335:491-495
25. Gogos CA, Giali S, Paliogianni F, Dimitracopoulos G, Bassaris HP, Vagenakis AG. Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia. 2001;44:1011-1014
26. Hoffman WH, Cudrici CD, Zafranskaia E, Rus H. Complement activation in diabetic ketoacidosis brains. Exp Mol Pathol. 2006;80:283-288
27. Jerath RS, Burek CL, Hoffman WH, Passmore GG. Complement activation in diabetic ketoacidosis and its treatment. Clin Immunol. 2005;116:11-17
28. Isales CM, Min L, Hoffman WH. Acetoacetate and betahydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications. 1999;13:91-97
29. Wootton-Gorges SL, Buonocore MH, Kuppermann N, et al. Detection of cerebral beta-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. Am J Neuroradiol. 2005;26:1286-1291
30. Persson B, Settergren G, Dahlquist G. Cerebral arterio-venous difference of acetoacetate and D-hydroxybutyrate in children. Acta Paediatr Scand. 1972;61:273-278
31. Kraus H, Schlenker S, Schwedesky D. Developmental changes of cerebral ketone body utilization in human infants. Hoppe Seylers Z Physiol Chem. 1974;355:164-170
32. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131-147
33. Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D. Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett. 2002;334:71-74
34. Wardlaw JM, Ferguson KJ, Graham C. White matter hyperintensities and rating scales-observer reliability varies with lesion load. J Neurol. 2004;251:584-590
35. Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology. 2004;63:1606-1612
36. Fernando MS, O'Brien JT, Perry RH, et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol. 2004;30:385-395
37. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391-1398
38. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37:550-555
39. Barltrop D. Lead and brain damage. Hum Toxicol. 1985;4:121
40. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria: a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res. 2004;1:91-110
41. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The encephalopathy associated with septic illness. Clin Invest Med. 1990;13:297-304
42. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G. The neuropathology of septic shock. Brain Pathol. 2004;14:21-33
43. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci U S A. 1997;94:227-232
44. Sharon M, Cassoria FG, Rose SR, Loriaux DL. Edema associated with improved glycemic control in an adolescent with type 1 diabetes. J Pediatr. 1987;111:403-404
45. Holsclaw DS Jr, Torcato B. Acute pulmonary edema in juvenile diabetic ketoacidosis. Pediatr Pulmonol. 1997;24:438-443
46. Hoffman WH, Locksmith JP, Burton EM, et al. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications. 1998;12:314-320
47. Morales AE, Rosenbloom AL. Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes. J Pediatr. 2004;144:270-273
48. Carchman RM, Dechert-Zeger M, Calikoglu AS, Harris BD. A new challenge in pediatric obesity: pediatric hyperglycemic hyperosmolar syndrome. Pediatr Crit Care Med. 2005;6:20-24